SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011226
Filing Date
2023-06-20
Accepted
2023-06-20 16:15:31
Documents
13
Period of Report
2023-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230616x8k.htm   iXBRL 8-K 46540
  Complete submission text file 0001558370-23-011226.txt   259522

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20230616.xsd EX-101.SCH 3265
3 EX-101.LAB elev-20230616_lab.xml EX-101.LAB 632
4 EX-101.PRE elev-20230616_pre.xml EX-101.PRE 10889
7 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230616x8k_htm.xml XML 5046
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 231025254
SIC: 2836 Biological Products, (No Diagnostic Substances)